Alto Neuroscience Inc. Common Stock (ANRO)

About ANRO

Alto Neuroscience, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's product pipeline includes ALTO-100, which is in Phase 2b clinical trial for the treatment of patients with bipolar depression (BPD). It also develops ALTO-300, a small molecule melatonergic agonist and serotonergic antagonist with antidepressant properties, which is in Phase 2b clinical trial to treat pa…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

68

Website

www.altoneuroscience.com

Fundamentals

1-day range

$29.88$32.19

Market cap

$1.06B

P/E (trailing)

—

P/E (forward)

-9.57

EPS (trailing)

$-2.32

Dividend yield

—

Beta

1.09

Avg. volume

517.5K

Forecasts

9 analyst ratings

Alto Neuroscience Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• ANRO

  Alto Neuroscience Inc. Common Stock

  $35.13

  ▼ 3.22%
  Market cap $1.06BP/E —
  $3.05$33.67
• LXRX

  Lexicon Pharmaceuticals Inc. Common Stock

  $2.29

  ▼ 1.29%
  Market cap $1.03BP/E —
  $1.03$2.68
• SVRA

  Savara Inc. Common Stock

  $5.27

  ▼ 4.10%
  Market cap $1.09BP/E —
  $3.19$7.01
• IVA

  Inventiva S.A. American Depository Shares

  $4.71

  ▼ 3.98%
  Market cap $1.00BP/E —
  $2.88$6.2
• CRVS

  Corvus Pharmaceuticals Inc. Common Stock

  $14.15

  ▼ 3.87%
  Market cap $1.12BP/E —
  $5.28$26.95
• OLMA

  Olema Pharmaceuticals Inc. Common Stock

  $10.28

  ▼ 4.77%
  Market cap $985.28MP/E —
  $5.36$36.26
• SDGR

  Schrodinger Inc. Common Stock

  $19.7

  ▼ 3.48%
  Market cap $1.14BP/E —
  $10.95$23.02

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Wedbush Maintains Neutral on Alto Neuroscience, Raises Price Target to $26
  Benzinga · 8/13/2026
• BTIG Maintains Buy on Alto Neuroscience, Raises Price Target to $37
  Benzinga · 8/13/2026
• Alto Neuroscience Q2 EPS $(0.65) Beats $(0.73) Estimate
  Benzinga · 8/12/2026
• Alto Neuroscience: Buy ALTO-207 Advancement TRD And Other Expansion Indications
  SeekingAlpha · 8/3/2026

• Andrew Craig Miller · May 27, 2026 · Grant

  26.0K
• Amit Etkin · May 14, 2026 · Gift

  400.0K
• Manji Husseini · May 12, 2026 · Grant

  11.0K
• York Gwill · May 12, 2026 · Grant

  11.0K
• Cox Christopher Nixon · May 12, 2026 · Grant

  11.0K
• Sanchez Ramiro · May 12, 2026 · Grant

  11.0K
• Dreyfus Andrew · May 12, 2026 · Grant

  11.0K
• Amit Etkin · March 1, 2026 · Tax Withholding

  6.2K @ $19.69
• Nicholas Conrad Smith · March 1, 2026 · Tax Withholding

  2.8K @ $19.69

Institutional Ownership

March 31, 2026

Total shares held

27.13M

Total value held

$599.59M

Institutional holders

108